Access to effective and affordable medicines is necessary for public health, social equity, and economic development, but the biopharmaceutical sector is not meeting that need, according to a released today by the National Academies of Sciences, Engineering, and Medicine. 鈥淥ur report seeks to address the market failures that currently permeate the biopharmaceutical sector, such as lack of competition due to distortions in the application of the patent protection process, the imbalance between the negotiating power of suppliers and purchasers, and the convoluted structure of the supply chain,鈥 the authors note. The report offers eight recommendations with 27 actions to improve the affordability of prescription drugs without discouraging the development of new and more effective drugs for the future. Among other measures, the report recommends improving methods for assessing the value that drugs provide and ensuring that incentives to develop drugs for rare diseases are not extended to widely sold drugs; taking actions to continually foster greater access to off-patent generic drugs; and discouraging direct-to-consumer advertisements for prescription drugs.聽

Related News Articles

Headline
The Centers for Medicare & Medicaid Services June 13 announced it approved state plan amendments to expand Medicaid access to care for tribal communities鈥
Headline
The departments of Health and Human Services, Labor, and the Treasury have certified two more independent dispute resolution entities, bringing the total鈥
Perspective
Public
The fate of the Trump administration鈥檚 legislative centerpiece 鈥 the One Big Beautiful Bill Act 鈥 continues to be the focal point in Washington, D.C.After the鈥
Headline
The Department of Health and Human Services and Centers for Medicare & Medicaid Services said June 3 they are rescinding 2022 CMS guidance with the subject鈥
Headline
The Government Accountability Office May 29 released a report recommending the Centers for Medicare & Medicaid Services target behavioral health services鈥
Perspective
Public
After approval in the House last week by a one vote margin, the One Big Beautiful Bill Act 鈥 a sweeping package that would enact many of President Trump鈥檚鈥